CA2202749C - Dc biopotential sensing electrode and electroconductive medium for use therein - Google Patents
Dc biopotential sensing electrode and electroconductive medium for use therein Download PDFInfo
- Publication number
- CA2202749C CA2202749C CA002202749A CA2202749A CA2202749C CA 2202749 C CA2202749 C CA 2202749C CA 002202749 A CA002202749 A CA 002202749A CA 2202749 A CA2202749 A CA 2202749A CA 2202749 C CA2202749 C CA 2202749C
- Authority
- CA
- Canada
- Prior art keywords
- electrode
- range
- medium
- sensing electrode
- biopotential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 46
- 229910052751 metal Inorganic materials 0.000 claims abstract description 27
- 239000002184 metal Substances 0.000 claims abstract description 27
- 239000004033 plastic Substances 0.000 claims abstract description 23
- 229920003023 plastic Polymers 0.000 claims abstract description 23
- 239000011248 coating agent Substances 0.000 claims abstract description 20
- 238000000576 coating method Methods 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims description 47
- 239000006071 cream Substances 0.000 claims description 30
- 229910052799 carbon Inorganic materials 0.000 claims description 19
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 17
- 230000004888 barrier function Effects 0.000 claims description 17
- 229910052709 silver Inorganic materials 0.000 claims description 17
- 239000004332 silver Substances 0.000 claims description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 239000004020 conductor Substances 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 14
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 14
- 239000011521 glass Substances 0.000 claims description 13
- 239000000853 adhesive Substances 0.000 claims description 11
- 230000001070 adhesive effect Effects 0.000 claims description 11
- 239000002984 plastic foam Substances 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 230000007797 corrosion Effects 0.000 claims description 7
- 238000005260 corrosion Methods 0.000 claims description 7
- 239000001103 potassium chloride Substances 0.000 claims description 7
- 235000011164 potassium chloride Nutrition 0.000 claims description 7
- 239000006260 foam Substances 0.000 claims description 6
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 229920001247 Reticulated foam Polymers 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 230000000717 retained effect Effects 0.000 claims description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims 21
- 229910001415 sodium ion Inorganic materials 0.000 claims 21
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims 15
- 229910001414 potassium ion Inorganic materials 0.000 claims 15
- 229920002457 flexible plastic Polymers 0.000 claims 6
- 238000007689 inspection Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 150000002500 ions Chemical class 0.000 abstract description 7
- 238000005259 measurement Methods 0.000 description 50
- 239000000499 gel Substances 0.000 description 32
- 238000012360 testing method Methods 0.000 description 30
- 201000010099 disease Diseases 0.000 description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- 239000000203 mixture Substances 0.000 description 15
- 238000012216 screening Methods 0.000 description 13
- 238000012545 processing Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 210000000481 breast Anatomy 0.000 description 10
- 230000006378 damage Effects 0.000 description 10
- 208000014674 injury Diseases 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000003745 diagnosis Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000012544 monitoring process Methods 0.000 description 7
- 230000005672 electromagnetic field Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 229920008790 Amorphous Polyethylene terephthalate Polymers 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000015654 memory Effects 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 4
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 229960002713 calcium chloride Drugs 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000028161 membrane depolarization Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N n-octadecyl alcohol Natural products CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000012883 sequential measurement Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- 206010000153 Abnormal labour Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 208000036365 Normal labour Diseases 0.000 description 1
- -1 Polyethylene glycerol stearate Polymers 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005234 chemical deposition Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- GTKRFUAGOKINCA-UHFFFAOYSA-M chlorosilver;silver Chemical compound [Ag].[Ag]Cl GTKRFUAGOKINCA-UHFFFAOYSA-M 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 229920003020 cross-linked polyethylene Polymers 0.000 description 1
- 239000004703 cross-linked polyethylene Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 238000000537 electroencephalography Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000013095 identification testing Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229910001510 metal chloride Inorganic materials 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 238000012567 pattern recognition method Methods 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004441 surface measurement Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/251—Means for maintaining electrode contact with the body
- A61B5/257—Means for maintaining electrode contact with the body using adhesive means, e.g. adhesive pads or tapes
- A61B5/259—Means for maintaining electrode contact with the body using adhesive means, e.g. adhesive pads or tapes using conductive adhesive means, e.g. gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0209—Special features of electrodes classified in A61B5/24, A61B5/25, A61B5/283, A61B5/291, A61B5/296, A61B5/053
- A61B2562/0215—Silver or silver chloride containing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Electrotherapy Devices (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/325,085 US5660177A (en) | 1991-11-04 | 1994-10-17 | D.C. biopotential sensing electrode assemblies for apparatus for disease, injury and bodily condition screening or sensing |
| US08/325,085 | 1994-10-17 | ||
| US08/508,206 US5823957A (en) | 1994-10-17 | 1995-07-27 | D.C. biopotential sensing electrode and electroconductive medium for use therein |
| US08/508,206 | 1995-07-27 | ||
| PCT/US1995/012525 WO1996011631A1 (en) | 1994-10-17 | 1995-10-16 | Dc biopotential sensing electrode and electroconductive medium for use therein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2202749A1 CA2202749A1 (en) | 1996-04-25 |
| CA2202749C true CA2202749C (en) | 2003-05-27 |
Family
ID=26984767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002202749A Expired - Fee Related CA2202749C (en) | 1994-10-17 | 1995-10-16 | Dc biopotential sensing electrode and electroconductive medium for use therein |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0786958A4 (es) |
| JP (1) | JPH10508227A (es) |
| AU (1) | AU3824495A (es) |
| BR (1) | BR9509370A (es) |
| CA (1) | CA2202749C (es) |
| IL (1) | IL115524A (es) |
| MX (1) | MX9702807A (es) |
| WO (1) | WO1996011631A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6032064A (en) * | 1996-10-11 | 2000-02-29 | Aspect Medical Systems, Inc. | Electrode array system for measuring electrophysiological signals |
| AU779506B2 (en) * | 1996-10-11 | 2005-01-27 | Covidien Lp | Method for measuring electrophysiological signals |
| US6394953B1 (en) | 2000-02-25 | 2002-05-28 | Aspect Medical Systems, Inc. | Electrode array system for measuring electrophysiological signals |
| US5895298A (en) * | 1997-05-29 | 1999-04-20 | Biofield Corp. | DC biopotential electrode connector and connector condition sensor |
| EP1898782B1 (en) | 2005-07-01 | 2016-04-06 | Impedimed Limited | Monitoring system |
| KR102194246B1 (ko) | 2013-11-27 | 2020-12-22 | 삼성전자주식회사 | 생체용 전극 및 이를 포함하는 생체 신호 측정 장치 |
| KR101649074B1 (ko) * | 2015-04-09 | 2016-08-17 | 이경호 | 세포간 전위차를 측정하는 방법 및 이를 이용한 유방암 감별시스템 |
| WO2024163346A1 (en) * | 2023-01-30 | 2024-08-08 | Edwards Lifesciences Corporation | Sensor with electrodes having gel containment features |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3027333A (en) * | 1957-12-30 | 1962-03-27 | Burton Parsons Chemicals Inc | Electrically conductive emulsions |
| US3828766A (en) * | 1972-08-14 | 1974-08-13 | Jet Medical Prod Inc | Disposable medical electrode |
| US3976055A (en) * | 1973-12-17 | 1976-08-24 | Ndm Corporation | Electrode and conductor therefor |
| US3964469A (en) * | 1975-04-21 | 1976-06-22 | Eastprint, Inc. | Disposable electrode |
| GB1594214A (en) * | 1977-01-21 | 1981-07-30 | Cardio Tech | Body electrodes |
| US4282878A (en) * | 1979-08-17 | 1981-08-11 | Vaughn Corporation | Electrode structure for electrocardiograph and related physiological measurements and the like |
| US4406827A (en) * | 1979-09-04 | 1983-09-27 | Minnesota Mining And Manufacturing Company | Cohesive nonsticky electrically conductive gel composition |
| US4365634A (en) * | 1979-12-06 | 1982-12-28 | C. R. Bard, Inc. | Medical electrode construction |
| US4570637A (en) * | 1983-10-20 | 1986-02-18 | Andover Medical Incorporated | Electrode |
| US4617935A (en) * | 1985-03-12 | 1986-10-21 | Ndm Corporation | Medical electrode |
| US4685467A (en) * | 1985-07-10 | 1987-08-11 | American Hospital Supply Corporation | X-ray transparent medical electrodes and lead wires and assemblies thereof |
| US5415164A (en) * | 1991-11-04 | 1995-05-16 | Biofield Corp. | Apparatus and method for screening and diagnosing trauma or disease in body tissues |
| US5499628A (en) * | 1993-08-27 | 1996-03-19 | Micron Medical Products, Inc. | Medical electrode |
-
1995
- 1995-10-05 IL IL11552495A patent/IL115524A/en not_active IP Right Cessation
- 1995-10-16 BR BR9509370A patent/BR9509370A/pt not_active IP Right Cessation
- 1995-10-16 AU AU38244/95A patent/AU3824495A/en not_active Abandoned
- 1995-10-16 MX MX9702807A patent/MX9702807A/es unknown
- 1995-10-16 WO PCT/US1995/012525 patent/WO1996011631A1/en not_active Application Discontinuation
- 1995-10-16 EP EP95936217A patent/EP0786958A4/en not_active Withdrawn
- 1995-10-16 JP JP8513253A patent/JPH10508227A/ja active Pending
- 1995-10-16 CA CA002202749A patent/CA2202749C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10508227A (ja) | 1998-08-18 |
| IL115524A (en) | 2001-07-24 |
| CA2202749A1 (en) | 1996-04-25 |
| WO1996011631A1 (en) | 1996-04-25 |
| EP0786958A4 (en) | 1999-02-03 |
| MX9702807A (es) | 1998-02-28 |
| IL115524A0 (en) | 1996-01-19 |
| BR9509370A (pt) | 1998-07-07 |
| AU3824495A (en) | 1996-05-06 |
| EP0786958A1 (en) | 1997-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5823957A (en) | D.C. biopotential sensing electrode and electroconductive medium for use therein | |
| US5660177A (en) | D.C. biopotential sensing electrode assemblies for apparatus for disease, injury and bodily condition screening or sensing | |
| AU686142B2 (en) | Screening and diagnosing trauma in body tissue | |
| US5895298A (en) | DC biopotential electrode connector and connector condition sensor | |
| CA1232947A (en) | Method and apparatus for monitoring redox reactions | |
| US5320101A (en) | Discriminant function analysis method and apparatus for disease diagnosis and screening with biopsy needle sensor | |
| US3971366A (en) | Apparatus and method for measuring the condition of the meridians and the corresponding internal organs of the living body | |
| US5697369A (en) | Method and apparatus for disease, injury and bodily condition screening or sensing | |
| US4126126A (en) | Non-metallic pregelled electrode | |
| US4643193A (en) | ECG electrode with sensing element having a conductive coating in a pattern thereon | |
| US5353802A (en) | Device for measurement of electrical impedance of organic and biological materials | |
| JP3328290B2 (ja) | イオン導入サンプリング装置および方法 | |
| US6269265B1 (en) | Apparatus and method for evoking and capturing a sweat sample | |
| CA2202749C (en) | Dc biopotential sensing electrode and electroconductive medium for use therein | |
| US4303076A (en) | Probe for transcutaneous sampling | |
| MXPA97002807A (es) | Electrodo de deteccion biopontencial de c.d. y medio electroconductor para utilizarse en el | |
| US5427098A (en) | Noninvasive method for determining treatment based upon lesion cell proliferation measurements | |
| Meroni et al. | Measurement of electrical impedance in different ex-vivo tissues | |
| McMechan et al. | Body surface ECG potential maps in acute myocardial infarction | |
| US4862092A (en) | Apparatus and method for in vitro detection of abnormal tissues | |
| Faupel et al. | Dedicated systems for surface electropotential evaluation in the detection and diagnosis of neoplasia | |
| US11166651B2 (en) | Measuring arrangement and method for in-vivo determination of the lactate concentration in blood by means of electrochemical impedance spectroscopy | |
| Grossen-Linden-Leihgestern | PHYSIOLOGICAL QUANTITIES | |
| Santoso et al. | Development of Flexible Electrode-Based SEMG Instrumentation System for Effortful Swallow Evaluation on Suprahyoid Muscles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |